{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:00:46Z","timestamp":1770750046029,"version":"3.50.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The clinical features of interstitial lung disease (ILD) in patients with dermatomyositis (DM) and negative myositis autoantibodies had not been exactly demonstrated previously. This study aimed to describe and expand the phenotype of interstitial lung disease (ILD) in this cohort of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 1125 consecutive Chinese patients with idiopathic inflammatory myopathies (IIM) between 2006 and 2020 were screened retrospectively. All proven cases of isolated ILD with both negative myositis-specific autoantibodies (MSA) and negative myositis-associated autoantibodies (MAA) were selected for inclusion. The clinical features and outcome among this group, MDA5<jats:sup>+<\/jats:sup>DM (DM patients with positive anti-MDA5 antibody) and ASS (patients with positive anti-aminoacyl tRNA synthetases antibodies were recorded and compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 1125 IIM patients with an average follow-up of 6 years, 154 DM patients with negative MSA and MAA (MSA\/MAA) were identified, with an ILD incidence of 46.8%. DM-ILD Patients with negative MSA\/MAA presented younger age at onset (p&amp;lt;0.001), lower incidence of elevated CA153 (p=0.03) and fever (p=0.04)than those ILD patients with MDA5<jats:sup>+<\/jats:sup>DM and ASS.The estimated high-resolution computed tomography patterns of ILD showed non-specific interstitial pneumonia (66.6%), followed by organizing pneumonia in patients with negative MSA\/MAA. OP pattern was more common in patients with MDA5<jats:sup>+<\/jats:sup>DM (69.7%), and the ratios of the OP (48.7%) and NSIP (51.3%) patterns were almost equal in patients with ASS. Of these DM-ILD patients with negative MSA\/MAA, 25% developed rapidly progressive interstitial lung disease (RP-ILD). Patients with RP-ILD had a shorter disease duration (p=0.002), higher percentage of positive ANA(p=0.01) and organizing pneumonia patterns (p=0.04), elevated CYFRA211(p=0.04) and decreased FiO2\/PaO2 (p&amp;lt;0.001) than those with chronic progressive ILD. The incidence of OP pattern in RP-ILD patients with negative MSA\/MAA was lower than in those RPILD patients with MDA5<jats:sup>+<\/jats:sup> DM (75%) and ASS (89%) (p=0.006). The cumulative 5- and 10-year survival rates in the DM-ILD patients with negative MSA\/MAA were 91% and 88%, respectively, during the long-term follow-up study. And they had more favorable survival rate compared with ILD patients with MDA5<jats:sup>+<\/jats:sup>DM and ASS (p&amp;lt;0.001). An independent prognostic factor was identified as decreased PaO2\/FiO2 (hazard ratio, 0.97; p=0.004].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study indicates DM-ILD patients with negative MSA\/MAA had favorable long-term outcomes. Decreased baseline PaO2\/FiO2 acted as an independent prognostic factor for this group of patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.879266","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T06:17:07Z","timestamp":1651817827000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort"],"prefix":"10.3389","volume":"13","author":[{"given":"Fang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.120","article-title":"Inflammatory Myopathies: Choosing the Right Biomarkers to Predict ILD in Myositis","volume":"12","author":"Gono","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classifcation and Management of Adult Infammatory Myopathies","volume":"7","author":"Selva-O\u2019Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04911-7","article-title":"The Significance of Myositis Autoantibodies in Idiopathic Inflammatory Myopathy Concomitant With Interstitial Lung Disease","volume":"42","author":"Huang","year":"2021","journal-title":"Neurol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009727","article-title":"Different Phenotypes in Dermatomyositis Associated With Anti-MDA5 Antibody: Study of 121 Cases","volume":"95","author":"Allenbach","year":"2020","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2217\/ijr.10.48","article-title":"Clinical and Pathophysiological Significance of Myositis-Specific and Myositis-Associated Autoantibodies","volume":"5","author":"Nakashima","year":"2010","journal-title":"Int J Clin Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-215004","article-title":"Anti-Ro52 Autoantibodies Are Associated With Interstitial Lung Disease and More Severe Disease in Patients With Juvenile Myositis","volume":"78","author":"Sabbagh","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.07.020","article-title":"Clinical Characteristics of Dermatomyositis Patients With Isolated Anti-Ro-52 Antibody Associated Rapid Progressive Interstitial Lung Disease: Data From the Largest Single Chinese Center","volume":"155","author":"Chen","year":"2019","journal-title":"Respir Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"ENMC 239th Workshop Study Group. 239th ENMC International Workshop: Classification of Dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical Manifestation and Prognostic Factor in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Associated Interstitial Lung Disease as a Complication of Dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatol (Oxf)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An Official American Thoracic Society\/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161480","article-title":"Clinical Profiles and Prognosis of Patients With Distinct Antisynthetase Autoantibodies","volume":"44","author":"Shi","year":"2017","journal-title":"J Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2323-y","article-title":"Anti-MDA5 Antibody is Associated With A\/SIP and Decreased T Cells in Peripheral Blood and Predicts Poor Prognosis of ILD in Chinese Patients With Dermatomyositis","volume":"32","author":"Chen","year":"2012","journal-title":"Rheumatol Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S310917","article-title":"Correlation Between Serum Tumor Marker Levels and Connective Tissue Disease-Related Interstitial Lung Disease","volume":"14","author":"Bao","year":"2021","journal-title":"Int J Gen Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa843","article-title":"Cytokeratin 19 Fragment is Associated With Severity and Poor Prognosis of Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Dermatomyositis","volume":"60","author":"Gui","year":"2021","journal-title":"Rheumatol (Oxf)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa819","article-title":"Elevated Carcinoembryonic Antigen Predicts Rapidly Progressive Interstitial Lung Disease in Clinically Amyopathic Dermatomyositis","volume":"60","author":"Zhu","year":"2021","journal-title":"Rheumatol (Oxf)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa034","article-title":"Clinical Significance of Radiological Patterns of HRCT and Their Association With Macrophage Activation in Dermatomyositis","volume":"59","author":"Zuo","year":"2020","journal-title":"Rheumatol (Oxf)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2019.3634","article-title":"Clinical Features and Poor Prognostic Factors of Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis With Rapid Progressive Interstitial Lung Disease","volume":"29","author":"Motegi","year":"2019","journal-title":"Eur J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2015.1091155","article-title":"Clinical Subsets Associated With Different Anti-Aminoacyl Transfer RNA Synthetase Antibodies and Their Association With Coexisting Anti-Ro52","volume":"26","author":"Yamasaki","year":"2016","journal-title":"Mod Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.04.057","article-title":"Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease: The FLAIR Model","volume":"158","author":"Lian","year":"2020","journal-title":"Chest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa266","article-title":"The Characteristics of Lymphocytes in Patients Positive for Anti-MDA5 Antibodies in Interstitial Lung Disease","volume":"59","author":"Huang","year":"2020","journal-title":"Rheumatol (Oxf)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.879266\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T06:17:09Z","timestamp":1651817829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.879266\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2022.879266"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.879266","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]},"article-number":"879266"}}